Latest Mesenchymal stem cell Stories
Stemedica announced today that it has received Institutional Review Board (IRB) approval from the University of California, San Diego (UCSD) to initiate a Stemedica clinical study entitled, "A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke". San Diego, CA (PRWEB) February 17, 2011 Stemedica Cell Technologies, Inc., a...
Stem Cell scientists in Australia have found that patients suffering from hearing problems which began during infancy and childhood could benefit from a transplant of stem cells from their nose.
Successful intranasal delivery of stem cells to the brains of rats with Parkinson disease yielded significant improvement in motor function and reversed the dopamine deficiency characteristic of the disease.
In work that could jumpstart the promising field of cell therapy, in which cells are transplanted into the body to treat a variety of diseases and tissue defects, researchers at Brigham and Womenâ€™s Hospital (BWH) have engineered cells that could solve one of the key challenges associated with the procedure: control of the cells and their microenvironment following transplantation.
Scientists from A*STARâ€™s Institute of Medical Biology (IMB) in Singapore and the University of Hong Kongâ€™s Department of Medicine have produced the world's first human cell model of progeria, a disease resulting in severe premature ageing in one in four to eight million children worldwide.
Scientists at the University of Michigan Comprehensive Cancer Center have identified a potential new way of attacking breast cancer stem cells, the small number of cells in a tumor that fuel its growth and spread.
DALLAS, January 11, 2011 /PRNewswire/ -- Sandler Research announces it will carry Mesenchymal Stem Cells (MSCs) - Advances & Applications Research Report in its store. Browse the complete Report on: http://www.sandlerresearch.org/reports/53195-mesenchymal-stem-.html Browse All Healthcare Reports at http://www.sandlerresearch.org/market-research/healthcare/ This is an expanded and updated report that includes: - 55 New Pages of Material - Charts, Timelines, Metrics...
High stem cell count after transplant predicts debilitating syndrome, U-M research finds.
Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes.
As debilitating as disease can be, finding paths that could possibly lead to a cure is quite rewarding.
- Withering but not falling off, as a blossom that persists on a twig after flowering.